Overview:
This four-hour course is aimed at attendees who wish to improve their
knowledge and understanding of cardiovascular MR techniques. There is a
strong emphasis on how new and evolving technologies can be exploited to
improve diagnostic capability, and it is therefore appropriate to
clinician and scientist alike. Concepts explored include techniques in
widespread clinical use (body/peripheral MRA), techniques that are now
evolving into the clinical arena (coronary MRA, non-contrast
techniques), benefits of 3T cardiovascular MRI (including parallel
cardiovascular MRI at such a field), structural versus functional
assessment of the heart, and the application of MRI in non-coronary
artery disease.
|
Educational Objectives:
Upon completion of this session, participants should be able to: |
|
· |
Implement a robust protocol for clinical
evaluation of arteries with both non-contrast and
contrast-enhanced techniques; |
|
· |
Identify the strengths and weaknesses of 3T MRI
vs. 1.5T MRI for cardiovascular assessment; |
|
· |
Recognize the value of parallel imaging for
cardiovascular assessment at higher magnetic filed (>1.5 T); |
|
• |
Select a comprehensive time-efficient protocol
incorporating anatomical and functional cardiac evaluation; |
|
• |
Explain the value of MRI for the assessment of
non-coronary artery disease; and |
|
· |
Recognize the strengths, and also the limitations
of current techniques. |
|
|
|
Audience
Description:
This course is designed for both clinicians and scientists who are
interested in understanding the strengths and the limitations of current
cardiovascular MRI techniques and developing new cardiovascular MRI
techniques to overcome the limitations of current techniques. |
Program |
|
Tuesday, 9 May |
|
MR Angiography |
|
| 07:00 |
Body &
Peripheral MRA |
Thomas M. Grist,
M.D. |
| 07:20 |
Non-contrast MRA |
Mitsue Miyazaki,
Ph.D. |
| 07:40 |
Coronary MRA |
René M. Botnar, Ph.D. |
| Wednesday,
10 May |
|
Cardiovascular MRI at High
Field – Is 3T better than 1.5T? |
|
| 07:00 |
MRA at 3.0T |
Neil M. Rofsky,
M.D. |
| 07:20 |
Cardiac MRI at
3.0T |
J. Paul Finn,
M.D. |
| 07:40 |
Cardiovascular Parallel
Imaging at 3.0T |
Thoralf Niendorf, Ph.D. |
|
Thursday, 11 May |
|
MRI of Myocardial
Function, Perfusion and Viability |
|
| 07:00 |
MRI of Global
and Regional Myocardial Function |
Leon Axel, Ph.D,
M.D. |
| 07:20 |
MRI of
Myocardial Perfusion |
Steven D. Wolff,
M.D., Ph.D. |
| 07:40 |
MRI of Myocardial Viability |
Raymond J. Kim, M.D. |
|
Friday, 12 May |
|
MRI of Non-coronary Artery
Disease |
|
| 07:00 |
Arrthymogenic Conditions |
David A. Bluemke,
M.D., Ph.D. |
| 07:30 |
Other Cardiomyopathies |
Jeanette Schulz-Menger,
M.D. |
|